Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360K Sell
14,948
-1,213
-8% -$31.7K 0.18% 69
2026
Q1
$454K Buy
16,161
+6,660
+70% +$177K 0.3% 54
2025
Q4
$237K Buy
+9,501
New +$240K 0.18% 75

Other funds holding PFE

Dutch Asset Corp's PFE Position: Q2 2026 in Review

Dutch Asset Corp reduced its Pfizer (PFE) stake by 7.5% in Q2 2026, selling an estimated $31.7K and leaving 14,948 shares worth $360K. The position accounts for 0.18% of the portfolio, ranked #69.

Dutch Asset Corp first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $454K in Q1 2026. 2,814 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Dutch Asset Corp held 14,948 shares of Pfizer worth $360K as of Q2 2026.
  • Dutch Asset Corp sold 1,213 Pfizer shares in Q2 2026, an estimated $31.7K.
  • Pfizer made up 0.18% of Dutch Asset Corp's portfolio in Q2 2026, its #69 holding.
  • Dutch Asset Corp first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Dutch Asset Corp's Pfizer position peaked at $454K in Q1 2026.
  • 2,814 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Dutch Asset Corp's 13F filing for Q2 2026, filed 10 Aug 2026.